II, Based on my declining memory, past announcements from ACW have stated a study/trial being conducted by Oxford University. Can't recall what Oxford Uni are targeting at time of writing but ACW are advising and providing XANAMEM free of charge but it is being conducted by Oxford Uni at no cost to ACW. Results are a yr or more away I believe. This is what Q v F could referring to as a 4th indication.
Yesterday's example of US $1Billion offer for an Alzeimers drug Biotech, page-8
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
0.005(17.2%) |
Mkt cap ! $91.19M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.5¢ | 2.9¢ | $185.6K | 5.882M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103275 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 119931 | 1 |
View Market Depth
| Last trade - 15.59pm 10/06/2024 (20 minute delay) ? |
|
|||||
|
Last
3.4¢ |
Change
0.005 ( 21.4 %) |
||||
| Open | High | Low | Volume | ||
| 2.9¢ | 3.5¢ | 2.9¢ | 1371485 | ||
| Last updated 15.59pm 10/06/2024 ? | |||||
| ACW (ASX) Chart |